Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 104142-93-0
2. 68077-27-0
3. Norfloxacin (hydrochloride)
4. Norfloxacin Hcl
5. Norfloxacin Hydrochloride(1:x)
6. Mk-0366 (hydrochloride)
7. 7o3ula741z
8. 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid;hydrochloride
9. 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hydrochloride
10. Unii-7o3ula741z
11. Norfloxacinhydrochloride
12. Schembl3147077
13. Chembl4635810
14. Hy-b0132a
15. Norfloxacin Hydrochloride (1:x)
16. Norfloxacin Monohydrochloride
17. Mfcd01075766
18. Akos015914287
19. Cs-1907
20. 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid,hydrochloride
21. As-82092
22. Norfloxacin Hydrochloride [who-dd]
23. Q27268636
24. 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic Acid Hydrochloride
25. 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
26. 3-quinolinecarboxylic Acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride (1:1)
Molecular Weight | 355.79 g/mol |
---|---|
Molecular Formula | C16H19ClFN3O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 355.1098973 g/mol |
Monoisotopic Mass | 355.1098973 g/mol |
Topological Polar Surface Area | 72.9 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 519 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Norfloxacin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norfloxacin Hydrochloride, including repackagers and relabelers. The FDA regulates Norfloxacin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norfloxacin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Norfloxacin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Norfloxacin Hydrochloride supplier is an individual or a company that provides Norfloxacin Hydrochloride active pharmaceutical ingredient (API) or Norfloxacin Hydrochloride finished formulations upon request. The Norfloxacin Hydrochloride suppliers may include Norfloxacin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Norfloxacin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Norfloxacin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Norfloxacin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Norfloxacin Hydrochloride GMP manufacturer or Norfloxacin Hydrochloride GMP API supplier for your needs.
A Norfloxacin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Norfloxacin Hydrochloride's compliance with Norfloxacin Hydrochloride specifications and serves as a tool for batch-level quality control.
Norfloxacin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Norfloxacin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Norfloxacin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Norfloxacin Hydrochloride EP), Norfloxacin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Norfloxacin Hydrochloride USP).
LOOKING FOR A SUPPLIER?